Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer
中国医学科学杂志(英文版)2010年第4期 页码:206-210
• Original Article •|Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer
Affiliations:
Department of Gastroenterology, The Military General Hospital of Beijing, Beijing 100700, China"
Author bio:
Funds:
DOI:
中图分类号:
网络出版日期:2010-12-20,
纸质出版日期:2010
Accepted:
Scan QR Code
Peng Jin, Jian-qiu Sheng, Ying-hui Zhang, 等. Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer[J]. 中国医学科学杂志(英文版), 2010,(4):206-210.
Peng Jin, Jian-qiu Sheng, Ying-hui Zhang, et al. Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer[J]. Chinese medical sciences journal, 2010, (4): 206-210.
Peng Jin, Jian-qiu Sheng, Ying-hui Zhang, 等. Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer[J]. 中国医学科学杂志(英文版), 2010,(4):206-210.DOI:
Peng Jin, Jian-qiu Sheng, Ying-hui Zhang, et al. Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer[J]. Chinese medical sciences journal, 2010, (4): 206-210.DOI:
Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer
Objective To investigate cyclooxygenase-2 (COX-2) expression and its relationship with mismatch repair (MMR) protein expression and microsatellite instability (MSI) in hereditary nonpolyposis colorectal cancer (HNPCC). Methods A total of 28 cases of colorectal adenoma and 14 cases of colorectal carcinoma were collected between July 2003 and July 2007 from 33 HNPCC families. Sporadic colorectal adenoma (n=32) and carcinoma patients (n=24) served as controls. With samples of tumor tissues and normal colonic mucosa collected from the patients
the protein expressions of COX-2 and MMR (hMLH1
hMSH2
and hMSH6) were examined with immunohistochemical assay. Frequency of MSI in five standard MSI loci BAT25
BAT26
D2S123
D5S346
and D17S250 were analyzed by means of polymerase chain reaction. Results The rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma
respectively. That rate was lower in HNPCC carcinoma than in sporadic carcinoma (P<0.05). MMR-deletion rate and percentage of high-frequency MSI (MSI-H) in HNPCC carcinoma were higher than those in sporadic colorectal carcinoma [both 71.4% (10/14) vs. 12.5% (3/24)
both P<0.01]. Among the 10 MMR-deficient HNPCC carcinoma patients
COX-2 low-expression was observed in 8 cases (80.0%)
while COX-2 high-expression was observed in all of the 4 MMR-positive HNPCC carcinoma cases (P<0.05). In comparison to MMR positive HNPCC carcinoma
HNPCC adenoma
and sporadic carcinoma
COX-2 expression was significantly lower in corresponding MMR-deficient cases (all P<0.05). The rates of COX-2 low-expression in HNPCC adenoma
HNPCC carcinoma
and sporadic carcinoma with MSI-H were significantly higher than those in the cases with microsatellite stability (all P<0.05). Conclusion COX-2 is expressed at a low level in HNPCC carcinoma
different from the high COX-2 expression in sporadic carcinoma.
Abstract
Objective To investigate cyclooxygenase-2 (COX-2) expression and its relationship with mismatch repair (MMR) protein expression and microsatellite instability (MSI) in hereditary nonpolyposis colorectal cancer (HNPCC). Methods A total of 28 cases of colorectal adenoma and 14 cases of colorectal carcinoma were collected between July 2003 and July 2007 from 33 HNPCC families. Sporadic colorectal adenoma (n=32) and carcinoma patients (n=24) served as controls. With samples of tumor tissues and normal colonic mucosa collected from the patients
the protein expressions of COX-2 and MMR (hMLH1
hMSH2
and hMSH6) were examined with immunohistochemical assay. Frequency of MSI in five standard MSI loci BAT25
BAT26
D2S123
D5S346
and D17S250 were analyzed by means of polymerase chain reaction. Results The rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma
respectively. That rate was lower in HNPCC carcinoma than in sporadic carcinoma (P<0.05). MMR-deletion rate and percentage of high-frequency MSI (MSI-H) in HNPCC carcinoma were higher than those in sporadic colorectal carcinoma [both 71.4% (10/14) vs. 12.5% (3/24)
both P<0.01]. Among the 10 MMR-deficient HNPCC carcinoma patients
COX-2 low-expression was observed in 8 cases (80.0%)
while COX-2 high-expression was observed in all of the 4 MMR-positive HNPCC carcinoma cases (P<0.05). In comparison to MMR positive HNPCC carcinoma
HNPCC adenoma
and sporadic carcinoma
COX-2 expression was significantly lower in corresponding MMR-deficient cases (all P<0.05). The rates of COX-2 low-expression in HNPCC adenoma
HNPCC carcinoma
and sporadic carcinoma with MSI-H were significantly higher than those in the cases with microsatellite stability (all P<0.05). Conclusion COX-2 is expressed at a low level in HNPCC carcinoma
different from the high COX-2 expression in sporadic carcinoma.